Zenvia Inc.ZENVNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank17
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P17
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2024-10.88%
2023-17.62%
202238.36%
2021196.14%
202059.04%
2019150.11%
20180.00%